Vailoces, Jovit .
HRN: 24-48-29 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/08/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/08/2024
02/16/2024
IV
2.25gm
TID
Infected Woundf
Waiting Final Action
Indication: Empirical Escalation Type of Infection: BloodstreamBone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes